πŸ‡ΊπŸ‡Έ FDA
Patent

US 10632211

Demethylation to treat eye disease

granted A61KA61K31/706A61K48/005

Quick answer

US patent 10632211 (Demethylation to treat eye disease) held by The Regents of the University of California expires Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/706, A61K48/005, A61K48/0058, A61K48/0075